Clinical Trials Directory

Trials / Completed

CompletedNCT06764992

Exploring Men s Prostate Cancer Genetic Risk Perceptions

Exploring Men s Prostate Cancer Genetic Risk Perceptions and Willingness to Give a Biospecimen for Genetic Risk Testing

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
Sex
Male
Age
40 Years
Healthy volunteers
Accepted

Summary

The exploring men's prostate cancer genetic risk perceptions and willingness to give a biospecimen for genetic risk testing study aims to assess prostate cancer genetic risk and susceptibility beliefs among unaffected men of diverse races/ethnicities who are considering undergoing prostate cancer screening and their willingness of men to provide a biospecimen (saliva sample) and test the samples for prostate cancer aggressiveness and determine risk category based on SNP genetic profile.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireParticipants will be asked to complete a questionnaire on demographics, risk beliefs and perception and prostate cancer screening behaviors, intentions and awareness of informed decision making.
OTHERSaliva SampleParticipants will be asked to provide a saliva sample for genetic risk testing to generate a SNP risk profile using a saliva sample collection kit with collection, storage and mailing instructions. We will assess the proportion of consented men who will provide a saliva sample.

Timeline

Start date
2022-08-25
Primary completion
2024-04-20
Completion
2024-06-07
First posted
2025-01-09
Last updated
2026-02-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06764992. Inclusion in this directory is not an endorsement.